Health FDA approved lung cancer drug created by Mirati to cost $19,750 for 180 tabletsdoha-review.comDecember 13, 2022 by doha-review.comDecember 13, 20220423 The US Food and Drug Administration has approved Mirati Therapeutics Inc’s lung cancer drug Adagrasib, according to the company, sending shares of the company up... Read more
